TRADITIONAL CHINESE MEDICINE CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

Name: No company name was provided. The business is a modern healthcare clinic in a high-growth U.S. urban market specializing in Traditional Chinese Medicine (TCM). It offers professional acupuncture, herbal therapy, and holistic wellness services on a fee-for-service basis, delivered by state-licensed practitioners who blend ancient TCM modalities with modern medical standards. One-line summary: launching in 2026 to deliver licensed, integrative TCM care to urban patients.

The clinic’s primary activities are patient intake, licensed practitioner treatment sessions, herbal dispensing, and coordinated care focused on high practitioner utilization and patient-centered outcomes. What sets the clinic apart is its emphasis on licensed clinical standards, scalable practitioner utilization, and a plan to expand from a small initial team into a multi-practitioner wellness hub by 2030. Short-term goal: open in 2026 and achieve target utilization; long-term goal: scale services and staff into a multi-practitioner hub by 2030. One-line summary: structured, license-driven TCM care designed to scale to a multi-practitioner hub by 2030.

Problem

Many American adults with chronic pain, stress, anxiety, and fertility challenges lack access to clinical, non-pharmacologic care. Conventional medicine often manages symptoms with medications or invasive procedures rather than offering integrative, root-cause treatments, leaving a sizable, underserved patient pool seeking safer alternatives.

Existing holistic options are commonly fragmented and nonclinical, creating barriers to consistent, evidence-informed care delivered by state-licensed practitioners. This gap reduces treatment continuity, lowers practitioner utilization, and limits access to specialized services that combine physical and mental health.

There is a clear need for a professional, fee-for-service clinic offering acupuncture, herbal therapy, and integrative care in a high-growth U.S. urban market. Such a clinic would provide regulated, scalable services that address unmet demand for clinical holistic care and improve patient outcomes.

Solution

Millions of Americans with chronic pain and stress need non‑invasive, root‑cause care as an alternative to surgery or long‑term pharmaceuticals. We deliver a full‑suite Traditional Chinese Medicine clinic offering personalized acupuncture, cupping, moxibustion, licensed practitioner diagnoses, and immediate access to custom‑blended, professional‑grade herbal formulas from an on‑site pharmacy, plus diet and lifestyle plans to drive long‑term wellness for urban adults aged 30–65.

One line: Clinical, licensed TCM care with same‑day herbal dispensing to reduce lead time and improve patient adherence.

Mission Statement

Our mission is to restore health and vitality in our community by blending the time-tested practices of Traditional Chinese Medicine with modern, integrative care to support long-term balance and well-being. We provide personalized, patient-centered therapies that prioritize prevention, the body's innate healing, and measurable outcomes. We commit to professional excellence, natural therapies, and community education to be the leading holistic healthcare option in the U.S.

Key Success Factors

Critical operational and market elements required to reach breakeven by February 2026 and sustain growth.

• Rapid breakeven: Achieve break-even by February 2026 to secure long-term stability.
• Practitioner utilization: Maintain 65% starting utilization, rising to 85% by 2030.
• In-house herbal pharmacy: Integrate pharmacy to add a diversified, high-margin revenue stream.
• Referral networks: Build strong referral links with local conventional medical providers for steady patient flow.
• Talent retention: Attract and retain licensed, high-quality practitioners to protect care standards and reputation.

Financial Summary

Concise financial snapshot: strong early breakeven, rapid scale to year‑5 revenue and EBITDA.

Financial requirements: minimum cash reserve $819,000 (required Feb‑26). Total capex $135,500; monthly rent $6,500. Anticipated return: IRR 12.26%, ROE 4.56%, breakeven Feb‑26 (2 months), full payback 14 months.

Overall outlook: profitable early, scaling to $2.75M revenue and $1.79M EBITDA by 2030.

Funding Requirements

We require $954,500 to complete buildout by March 2026 and fund launch and first‑year operations; projections show revenue growing from $439,000 in Year 1 to $2,750,000 by 2030, EBITDA rising from $139,000 to $1,794,000, an IRR of 12.26%, ROE of 4.56%, breakeven in 2 months, and a full payback in 14 months.